EA200500224A1 - МИКРОБИОЛОГИЧЕСКИЕ СПОСОБЫ ПОЛУЧЕНИЯ 7α-ЗАМЕЩЁННЫХ 11α-ГИДРОКСИСТЕРОИДОВ - Google Patents

МИКРОБИОЛОГИЧЕСКИЕ СПОСОБЫ ПОЛУЧЕНИЯ 7α-ЗАМЕЩЁННЫХ 11α-ГИДРОКСИСТЕРОИДОВ

Info

Publication number
EA200500224A1
EA200500224A1 EA200500224A EA200500224A EA200500224A1 EA 200500224 A1 EA200500224 A1 EA 200500224A1 EA 200500224 A EA200500224 A EA 200500224A EA 200500224 A EA200500224 A EA 200500224A EA 200500224 A1 EA200500224 A1 EA 200500224A1
Authority
EA
Eurasian Patent Office
Prior art keywords
hydroxysteroids
substituted
obtaining
microbiological methods
synthesis
Prior art date
Application number
EA200500224A
Other languages
English (en)
Other versions
EA008147B1 (ru
Inventor
Людвиг Цорн
Рольф Больманн
Норберт Галлус
Германн Кюнцер
Ханс-Петер Мун
Райнхард Нуббемейер
Original Assignee
Шеринг Акциенгезельшафт
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10233723A external-priority patent/DE10233723A1/de
Application filed by Шеринг Акциенгезельшафт filed Critical Шеринг Акциенгезельшафт
Publication of EA200500224A1 publication Critical patent/EA200500224A1/ru
Publication of EA008147B1 publication Critical patent/EA008147B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J11/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00—Preparation of steroids
    • C12P33/06—Hydroxylating
    • C12P33/08—Hydroxylating at 11 position
    • C12P33/10—Hydroxylating at 11 position at 11 alpha-position
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00—Preparation of steroids
    • C12P33/12—Acting on D ring
    • C12P33/16—Acting at 17 position

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Reproductive Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

В заявке описывается синтез нового типа форпродуктов, предназначенных для получения соединений общей формулы (8,10,12)При осуществлении этого синтеза в результате микробиологического превращения образуются соединения общей формулы (4,B)Значения остатков R, R, R, R, Rи R, а также группировки U-V-W-X-Y-Z указаны в формуле изобретения.Отчет о международном поиске был опубликован 2004.07.15.
EA200500224A 2002-07-24 2003-07-24 МИКРОБИОЛОГИЧЕСКИЕ СПОСОБЫ ПОЛУЧЕНИЯ 7α-ЗАМЕЩЁННЫХ 11α-ГИДРОКСИСТЕРОИДОВ EA008147B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10233723A DE10233723A1 (de) 2002-07-24 2002-07-24 Mikrobiologische Verfahren zur Herstellung von 7α-substituierten 11α-Hydroxysteroiden, daraus herstellbare 7α,17α-substituierte 11β-Halogensteroide, deren Herstellungsverfahren und Verwendung sowie pharmazeutische Präparate, die diese Verbindungen enthalten, sowie daraus herstellbare 7α-substituierte Estra-1,3,5(10)-triene
US40295302P 2002-08-14 2002-08-14
PCT/EP2003/008111 WO2004011663A2 (de) 2002-07-24 2003-07-24 Mikrobiologische verfahren zur herstellung von 7alpha-substituierten 11alpha-hydroxysteroiden

Publications (2)

Publication Number Publication Date
EA200500224A1 true EA200500224A1 (ru) 2005-08-25
EA008147B1 EA008147B1 (ru) 2007-04-27

Family

ID=31189296

Family Applications (2)

Application Number Title Priority Date Filing Date
EA200500224A EA008147B1 (ru) 2002-07-24 2003-07-24 МИКРОБИОЛОГИЧЕСКИЕ СПОСОБЫ ПОЛУЧЕНИЯ 7α-ЗАМЕЩЁННЫХ 11α-ГИДРОКСИСТЕРОИДОВ
EA200601030A EA010572B1 (ru) 2002-07-24 2003-07-24 7α,17α-ЗАМЕЩЕННЫЕ 11β-ГАЛОГЕНОСТЕРОИДЫ, СПОСОБЫ ИХ ПОЛУЧЕНИЯ, ПРИМЕНЕНИЕ И ФАРМАЦЕВТИЧЕСКИЙ ПРЕПАРАТ НА ИХ ОСНОВЕ

Family Applications After (1)

Application Number Title Priority Date Filing Date
EA200601030A EA010572B1 (ru) 2002-07-24 2003-07-24 7α,17α-ЗАМЕЩЕННЫЕ 11β-ГАЛОГЕНОСТЕРОИДЫ, СПОСОБЫ ИХ ПОЛУЧЕНИЯ, ПРИМЕНЕНИЕ И ФАРМАЦЕВТИЧЕСКИЙ ПРЕПАРАТ НА ИХ ОСНОВЕ

Country Status (20)

Country Link
EP (1) EP1523568A2 (ru)
JP (1) JP4417838B2 (ru)
KR (1) KR101041328B1 (ru)
CN (1) CN100339486C (ru)
BR (1) BR0313210A (ru)
CA (1) CA2492079C (ru)
CO (1) CO5690563A2 (ru)
CR (1) CR7672A (ru)
EA (2) EA008147B1 (ru)
EC (1) ECSP055630A (ru)
HK (1) HK1081999A1 (ru)
HR (1) HRP20050172A2 (ru)
IL (1) IL166358A0 (ru)
MX (1) MXPA05001024A (ru)
NO (1) NO20050980L (ru)
NZ (2) NZ537871A (ru)
PH (1) PH12005500143B1 (ru)
PL (1) PL373808A1 (ru)
RS (1) RS51855B (ru)
WO (1) WO2004011663A2 (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7935838B2 (en) * 2005-10-27 2011-05-03 Sri International Process for production of steroid compound
CN103834712B (zh) * 2012-11-26 2016-03-30 复旦大学 去氧孕烯中间体纳米脂质体生物转化的优化方法
CN103214543B (zh) * 2012-12-25 2015-09-02 中国人民解放军海军医学研究所 新山楂酸衍生物、其制备方法及其在抗肿瘤药物中的应用
CN104862323B (zh) * 2015-06-02 2018-01-16 中国农业科学院生物技术研究所 修饰苯二酚类化合物的羟化酶基因
PL442098A1 (pl) * 2022-08-26 2024-03-04 Uniwersytet Przyrodniczy we Wrocławiu Sposób wytwarzania 11α-hydroksy-19-nortestosteronu

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL75841C (ru) 1949-06-11
US2658023A (en) * 1953-04-21 1953-11-03 Pfizer & Co C Oxygenation of steroids
US2985563A (en) * 1958-11-13 1961-05-23 Schering Corp 11alpha-hydroxylation of steroids by glomerella
US3004047A (en) * 1959-03-13 1961-10-10 Olin Mathieson 6alpha-halo-11alpha-hydroxy steroids of the pregnane series and esters thereof
US3341557A (en) * 1961-06-05 1967-09-12 Upjohn Co 7-methyltestosterones
US3203869A (en) * 1962-10-11 1965-08-31 Syntex Corp 11alpha-hydroxylation of 6-substituted-11-desoxy steroids with microorganisms of thegenus fusarium, liseola section
US5342834A (en) 1989-04-07 1994-08-30 The Population Council, Inc. Method for androgen supplementation
EP1170299A3 (en) * 1995-12-11 2004-11-10 G.D. Searle & Co. Intermediates useful in the preparation of 9,11-epoxy steroids and methods for their production
GB9525194D0 (en) 1995-12-12 1996-02-07 Zeneca Ltd Pharmaceutical composition
WO1997021830A1 (en) 1995-12-12 1997-06-19 Akzo Nobel N.V. MICROBIAL 11α-HYDROXYLATION OF STEROIDS
US6767902B2 (en) 1997-09-17 2004-07-27 The Population Council, Inc. Androgen as a male contraceptive and non-contraceptive androgen replacement
US20020012694A1 (en) * 1997-09-17 2002-01-31 Alfred J. Moo-Young Transdermal administration of ment
US5952319A (en) 1997-11-26 1999-09-14 Research Triangle Institute Androgenic steroid compounds and a method of making and using the same
EE200200454A (et) 2000-02-15 2003-12-15 Schering Aktiengesellschaft Noretisterooni sisaldav meeste kontratseptiivne preparaat
DE10104327A1 (de) 2001-01-24 2002-07-25 Schering Ag 11beta-Halogensteroide, deren Herstellung und Verwendung zur Herstellung von Arzneimitteln sowie 11beta-Halogensteroide enthaltende pharmazeutische Präparate
KR20050025985A (ko) * 2002-07-25 2005-03-14 쉐링 악티엔게젤샤프트 안드로겐성 11β-할로겐 스테로이드 및 황체기 호르몬을함유하는 조성물 및 상기 조성물에 기초한 남성 피임제

Also Published As

Publication number Publication date
EP1523568A2 (de) 2005-04-20
MX260952B (ru) 2008-10-01
HK1081999A1 (en) 2006-05-26
NO20050980L (no) 2005-02-23
EA200601030A1 (ru) 2006-10-27
ECSP055630A (es) 2005-04-18
RS20050045A (en) 2007-06-04
WO2004011663A2 (de) 2004-02-05
CN100339486C (zh) 2007-09-26
PH12005500143B1 (en) 2011-03-25
BR0313210A (pt) 2005-06-28
EA010572B1 (ru) 2008-10-30
NZ549529A (en) 2008-04-30
CN1671858A (zh) 2005-09-21
WO2004011663A3 (de) 2004-07-15
WO2004011663A9 (de) 2004-05-06
RS51855B (sr) 2012-02-29
IL166358A0 (en) 2006-01-16
CO5690563A2 (es) 2006-10-31
CA2492079C (en) 2012-01-10
CR7672A (es) 2006-05-29
EA008147B1 (ru) 2007-04-27
NZ537871A (en) 2006-10-27
HRP20050172A2 (en) 2005-04-30
MXPA05001024A (es) 2005-05-16
JP2006503813A (ja) 2006-02-02
JP4417838B2 (ja) 2010-02-17
KR101041328B1 (ko) 2011-06-14
PL373808A1 (en) 2005-09-19
KR20050026507A (ko) 2005-03-15
AU2003281677A1 (en) 2004-02-16
CA2492079A1 (en) 2004-02-05

Similar Documents

Publication Publication Date Title
EA200500472A1 (ru) Ацетил 2-гидрокси-1,3-диаминоалканы
EA200500017A1 (ru) Новые соединения
ATE270817T1 (de) Fungizide
CA2379747A1 (en) Novel succinate derivative compounds useful as cysteine protease inhibitors
CY1105836T1 (el) 12, 13-τροποποιημενα παραγωγα εποθιλονης
EA200300017A1 (ru) Ингибиторы серинпротеазы
CA2408602A1 (en) Phenylglycine derivatives
EA200200510A1 (ru) 4-карбоксиамино-2-этил-1,2,3,4-тетрагидрохинолин в кристаллической форме как ингибитор сетр
DE60033689D1 (de) Inhibitoren von serinproteasen
ATE332304T1 (de) Cefdinir salze als zwischenprodukte
SE9903291D0 (sv) New process
MXPA03009548A (es) Arilsulfonamidas como agentes antivirales.
EA199900790A1 (ru) Способы получения пестицидных промежуточных соединений
TR200302288T2 (tr) Terapi için yeni bileşikler ve metotlar.
EA200500224A1 (ru) МИКРОБИОЛОГИЧЕСКИЕ СПОСОБЫ ПОЛУЧЕНИЯ 7α-ЗАМЕЩЁННЫХ 11α-ГИДРОКСИСТЕРОИДОВ
EA200200101A1 (ru) Получение замещенных пиперидин-4-онов
MXPA06003345A (es) Derivados de aminopiridina como inhibidores de la no-sintasa inducible.
IT1293777B1 (it) Processo per la preparazione di tetraazamacrocicli
ATE388957T1 (de) Herstellung von siliziumverbrückten metallocenverbindungen
EA199900235A1 (ru) Аморфные бензотиофены, способы получения и способы применения
EA200501244A1 (ru) Оксатиинкарбоксамиды
MXPA02001406A (es) Heterociclilos-2h-cromenos substituidos.
EA200400876A1 (ru) Способ получения производных толуола
PT1307436E (pt) Processo para a preparacao de derivados de bacatina iii
ID27440A (id) Proses untuk menyiapkan penengah-penengah

Legal Events

Date Code Title Description
PD4A Registration of transfer of a eurasian patent in accordance with the succession in title
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): BY RU